Clear misunderstanding of the financial world (as usual). These are massive prime brokers. Whilst individual aspects of JPM might, overall they don't give a crap about the direction of MSB's share price. Its not even on the company radar. It's just one of millions of financial assets around the world JPM churns custodial revenues in from providing custody, lending and hypothecation services, for fees.
The imagined manipulation of stocks a warm blanket of blame for those struggling to understand why their stocks are down.
The NASDAQ biotech index fell 6.6% on Tuesday after Vinay Prasad was named as the new director of the FDA's Center for Biologics Evaluation and Research (CBER). That was why MSB was down yesterday, for those unaware. Simple correlated early selling. It bounced from that yesterday and will likely continue a little today.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)